tiprankstipranks
Trending News
More News >
Chugai Pharmaceutical Co Ltd (CHGCF)
OTHER OTC:CHGCF
US Market

Chugai Pharmaceutical Co (CHGCF) Income Statement

Compare
22 Followers

Chugai Pharmaceutical Co Income Statement

Last quarter (Q3 2025), Chugai Pharmaceutical Co's total revenue was ¥333.18B, an increase of 5.54% from the same quarter last year. In Q3, Chugai Pharmaceutical Co's net income was ¥111.21B. See Chugai Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
¥ 1.17T¥ 1.11T¥ 1.26T¥ 999.76B¥ 786.95B
Gross Profit
¥ 830.75B¥ 693.01B¥ 783.06B¥ 660.27B¥ 511.77B
Operating Expenses
¥ 286.84B¥ 277.34B¥ 249.12B¥ 226.53B¥ 204.89B
Depreciation and Amortization
¥ 31.66B¥ 31.74B¥ 31.43B¥ 30.87B¥ 30.48B
EBITDA
¥ 574.80B¥ 475.64B¥ 562.66B¥ 450.30B¥ 328.72B
Operating Income
¥ 543.91B¥ 415.67B¥ 533.94B¥ 433.74B¥ 306.88B
Other Income/Expenses
¥ -873.00M¥ 28.16B¥ -2.78B¥ -14.35B¥ -8.69B
Pretax Income
¥ 543.03B¥ 443.82B¥ 531.17B¥ 419.38B¥ 298.19B
Net Income
¥ 387.32B¥ 325.47B¥ 374.43B¥ 303.00B¥ 214.73B
Per Share Metrics
Basic EPS
¥ 235.39¥ 197.83¥ 227.64¥ 184.29¥ 130.66
Diluted EPS
¥ 235.36¥ 197.80¥ 227.57¥ 184.17¥ 130.53
Weighted Average Shares Outstanding
1.65B 1.65B 1.64B 1.64B 1.64B
Weighted Average Shares Outstanding (Diluted)
1.65B 1.65B 1.65B 1.65B 1.65B
Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History